These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25672371)

  • 21. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.
    Bogaczewicz A; Sobow T; Bogaczewicz J; Kaleta B; Sysa-Jedrzejowska A; Robak E; Lukaszkiewicz J; Dariusz S; Wozniacka A
    Lupus; 2013 Dec; 22(14):1504-8. PubMed ID: 24243911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate.
    Gińdzieńska-Sieśkiewicz E; Radziejewska I; Domysławska I; Klimiuk PA; Sulik A; Rojewska J; Gabryel-Porowska H; Sierakowski S
    Adv Med Sci; 2016 Sep; 61(2):193-197. PubMed ID: 26876088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-high mobility group box 1 (anti-HMGB1) antibodies are not related to the occurrence of cutaneous lesions in systemic lupus erythematosus.
    Tan G; Zhu N; Shi Z; Meng Z; Yu M; Li K; Yin J; Wei K; Mi X; Wang L
    Scand J Rheumatol; 2015; 44(2):150-6. PubMed ID: 25439526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
    J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
    Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
    J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides.
    Watson M; Rudd PM; Bland M; Dwek RA; Axford JS
    Arthritis Rheum; 1999 Aug; 42(8):1682-90. PubMed ID: 10446868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
    Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
    Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
    Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
    Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous.
    Noris-García E; Arce S; Nardin P; Lanigan ME; Acuña V; Gutierrez F; Robinson-Agramonte MA; Gonçalves CA
    Lupus; 2018 Nov; 27(13):2041-2049. PubMed ID: 30376438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies against polyriboadenylic acid in systemic lupus erythematosus and rheumatoid arthritis demonstrated by ELISA. Prevalence of and relation to antibodies against DNA and extractable nuclear antigens.
    Gripenberg M; Piirainen H; Linder E
    Scand J Rheumatol; 1981; 10(1):33-7. PubMed ID: 6971488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.
    Bobek D; Grčević D; Kovačić N; Lukić IK; Jelušić M
    Pediatr Rheumatol Online J; 2014; 12():50. PubMed ID: 25516724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypogammaglobulinemia in pediatric systemic lupus erythematosus.
    Lim E; Tao Y; White AJ; French AR; Cooper MA
    Lupus; 2013 Nov; 22(13):1382-7. PubMed ID: 24106215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I; Dostal C; Becvar R
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raised serum APRIL levels in patients with systemic lupus erythematosus.
    Koyama T; Tsukamoto H; Miyagi Y; Himeji D; Otsuka J; Miyagawa H; Harada M; Horiuchi T
    Ann Rheum Dis; 2005 Jul; 64(7):1065-7. PubMed ID: 15576416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
    Draborg AH; Jørgensen JM; Müller H; Nielsen CT; Jacobsen S; Iversen LV; Theander E; Nielsen LP; Houen G; Duus K
    Scand J Rheumatol; 2012 Aug; 41(4):280-9. PubMed ID: 22646970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.